Can a shingles shot protect vulnerable transplant patients?
NCT ID NCT06162494
Summary
This study is testing the safety and effectiveness of the shingles vaccine in young adults who have received a solid organ transplant, like a heart, liver, or kidney. Participants will receive two doses of the vaccine and be closely monitored for side effects and their immune response for over a year. The goal is to see if the vaccine can safely help prevent shingles in this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VARICELLA ZOSTER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ann & Robert H. Lurie Children's Hospital
Chicago, Illinois, 60611, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.